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ABSTRACT 
 
The primary objective of this study was to determine the effects of CDC-like kinase 1 
(CLK1) on the differentiation of a telogen skin stem cell line as a follow-up study to Dr. Lyle‟s 
previous work on the differentiation of hair follicle cells.  CLK1 knockdown strains were created 
using shRNA, then differentiated via several induction pathways.  Cells lacking CLK1 
differentiated along the sebocyte differentiation pathway similarly to the controls, but displayed 
no epidermal differentiation.  These results suggest that CLK1 is necessary for epidermal 
differentiation, but plays no role in the differentiation of sebocytes.  
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BACKGROUND 
 
Adult Stem Cell Theory 
 
It is generally known that some tissues contain adult stem cells that have the ability to 
replenish the tissue by differentiating into different cell types.  When a stem cell divides, it 
produces one new stem cell and one transit-amplifying (TA) cell (Roh et al., 2010).  The new 
daughter stem cell maintains the stem cell line, while the TA cell has the multi-potency to 
develop into various cell types characteristic of that tissue to help maintain tissues whose cells 
need replacement (Roh et al., 2004).  TA cells receive signals from the surrounding cells and 
environment to determine their differentiation pathway, a process which can be replicated in 
vitro (Clarke & Fuller, 2006).  The TA cells then undergo a series of cell divisions before 
becoming fully differentiated (Figure 1). 
 
 
 
Since stem cells have nearly unlimited self-renewal abilities, it is necessary for tissues to 
strictly regulate their divisions to prevent indefinite replication and growth.  Most tissues contain 
a very small number of adult stem cells that give rise to many TA cells to supply the tissue with 
Figure 1: Diagram of Stem Cell Differentiation.  Stem cells (dark blue, left) receive signals 
from the surrounding niche (green) and divide to create new stem cells (reverse arrow) and transit 
amplifying (TA) cells. TA cells undergo a series of divisions prior to becoming fully 
differentiated.  (Clarke & Fuller, 2006) 
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Figure 2. Schematic of the Skin Layers and Hair Follicle Structure. The 
skin is composed of three main layers (see the right side).  Hair follicles reside 
in the two outermost layers. (Natural Hair, 2009) 
the cells it requires for turnover (Clarke & Fuller, 2006).  TA cells go through limited cell 
divisions, thus the stem cells are the only long-lived cells within the tissue (Clarke & Fuller, 
2006).  In this way, mutation accumulation is minimized, and the regulation of growth is 
maintained (Clarke & Fuller, 2006). 
 
Stem Cells of the Human Skin 
Human Skin Growth and Biology 
While adult stem cells are likely important in all human organs, they are especially 
important in the skin.  As the largest organ of the human body, the skin is composed of various 
cell types, and it requires constant maintenance to remain healthy.  Human skin is comprised of 
three main layers: the epidermis, dermis, and subcutaneous tissue (Figure 2).   
 
 
 
Interspersed hair follicles traverse both the epidermis and dermis and are the location of 
our skin stem cell of interest, the telogen stem cell.  These stem cells are located in the bulge 
region of the hair follicle (Figure 3) (Roh et al., 2010).  Telogen stem cell differentiation is 
7 
 
Figure 3. The Location of Skin Stem Cells. Schematic of a hair follicle 
showing the bulge region (right side) which contains adult stem cells.  The 
stem cells produce TA cells that move vertically up or down the shaft to 
eventually replace other cells in the tissue. (Spradling et al., 2001) 
 
controlled by three hair growth stages: anagen (growth), catagen (regression), and telogen (rest) 
(Roh et al., 2008).  At anagen onset, the stem cells in the bulge are activated to proliferate, 
generating the lower follicle and promoting hair growth (Roh et al., 2008).  This phase lasts as 
long as the life of the individual hair, which can be up to eight years on the human scalp.  Then 
during catagen, the lower follicle regresses until there is no follicle below the bulge region (Roh 
et al., 2008).  Telogen is the period of rest where there is no hair growth in the follicle until the 
next anagen cycle.  Thus, telogen stem cells are cells in the stage of rest within the follicle bulge 
(Roh et al., 2008). 
 
  
 
Properties of Primary Skin Stem Cells 
Roh et al. have isolated and characterized primary skin stem cells based on their 
biochemical properties (2005).  As with all adult stem cells, it was shown that the division of a 
skin stem cell yields a daughter stem cell to maintain the stem cell line and a TA cell which will 
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differentiate into other skin cells (Roh et al., 2005).  The skin stem cells are biochemically and 
structurally undifferentiated, slow-cycling, and can renew without limits (Roh et al., 2005).  
Their location in the hair follicle bulge is similar to other known stem cell niches in the human 
body in that the stem cells are tightly adhered to membrane in a well-protected cavity (Roh et al., 
2005).   
Telogen stem cells are multi-potent and can differentiate into different types of skin cells 
including: hair, sebocyte, and epidermal cells (Roh et al., 2004).  These cells give rise to the 
lower hair follicle, hair shaft, sebaceous (sweat) glands, and the outer epidermis respectively 
(Roh et al., 2004).  In vitro, these cells can be induced to differentiate by culture components, or 
by cell signaling between dermal papilla cells and telogen stem cells, both of which were utilized 
in this MQP study (Roh et al., 2004). 
Roh et al. showed that keratin 15 (K15) and integrin β1 are markers for stem cells of the 
bulge area, and thus, they are often referred to as keratinocytes (2005).  Alternatively, TA cells 
express no K15 and much lower levels of β1 integrin than the primary stem cells (Roh et al., 
2005). 
 
Immortalized Skin Stem Cell Line Tel-E6E7 
Cell Line Creation 
In order to study the properties and behaviors of skin stem cells, an immortalized cell line 
was created by the Lyle lab and Cecillia Roh of Beth Israel Medical Center of Boston (Roh et al., 
2008).  Explained briefly, human telogen skin stem cells were extracted from adult scalp skin by 
chemical digestion and physical dissection (Roh et al., 2008).  The line was immortalized using a 
retroviral vector, then continually passaged to eliminate the possibility of cancerous cells (Roh et 
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Figure 4. Expression of Skin Stem Cell 
Markers in Immortal Tel-E6E7 Cells. 
Tel-E6E7 cells exhibit positive staining 
(green) for K15 (A) and β1 integrin (B) by 
IFA. (Roh et al., 2008) 
al., 2008).  The cell line was named Tel-E6E7, and will be referred to as such throughout this 
report (Roh et al., 2008). 
Similarities of Tel-E6E7 to Primary Skin Stem Cells 
 Roh et al. continued their study by comparing the 
properties the created Tel-E6E7 cells to those of primary 
skin stem cells (2008).  Immunofluorescence assays and 
Western blots were used to determine that the Tel-E6E7 
cells express K15 and β1 integrin, the same markers as 
primary skin stem cells (Figure 4) (Roh et al., 2008). 
 It was also determined by differentiation assays 
that the formation of three different cell lineages was 
possible for the Tel-E6E7 cells, indicating that they 
possess the same multi-potency as primary skin stem cells 
(Roh et al., 2008).  Additional assays measuring Tel-E6E7 
cell migration and adhesion illustrated slow movement and 
high adhesion, showing further similarities to primary skin 
stem cells (Roh et al., 2008). 
 
CDC-Like Kinases and CLK1 
It is generally understood that cellular development is partially regulated by various 
protein kinases.  CDC-like kinase (CLK) is a protein kinase with dual specificty; it can 
phosphorylate both serine/threonine and tyrosine residues (Roh et al., 2010).  CLKs are part of a 
protein kinase family which contains a conserved sequence at the C-terminus and the signature 
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Figure 5. Structure of CLK1. The C-terminus of CLK1 
contains the protein‟s catalytic site and the N-terminus 
contains substrate-binding and localization sites. 
(Debreczeni et al., 2005)  
amino acid motif „EHLAMMERILG‟ (Hanes et al., 1994).  This family is termed the LAMMER 
family and consists of CLK1-4, which differ mainly in their N-terminal regions (Nayler et al., 
1997). 
CLK1 was one of the first dual specificity kinases discovered (Menegay et al., 2000).  
CLK1 autophosphorylates serine, threonine, and tyrosine residues, and phosphorylates other 
substrate‟s serine and threonine residues (Ben-David et al., 1991).  The conserved C-terminus 
region contains the catalytic domain of the molecule (Figure 5).  The N-terminal domain 
includes a “functional nuclear localization signal which may direct CLK1 into the nucleus” and 
may also bind to substrate (Duncan et al., 1995; Menegay et al., 2000).  CLK1 can be negatively 
regulated by its own N-terminal domain, which when truncated increases enzymatic activity 
(Menegay et al., 2000).  The N-terminus was also shown to contain a regulatory region, 
including receptors for epidermal growth factor (EGF), as well as other growth factors (Menegay 
et al., 2000).  Additionally, through its interaction with SR-proteins, CLK1 regulates its own pre-
mRNA splicing (Duncan et al., 1997).   
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Interaction of CLK1 with SR-Proteins 
The primary mechanism through which CLK1 may be affecting stem cell differentiation 
is by phosphorylating the serine group of serine- and arginine-rich (SR) proteins.  SR proteins 
are stored in the nuclear speckles of the nucleoplasm and are partly responsible for the choice of 
splicing sites during pre-mRNA splicing (Duncan et al., 1997; Misteli et al., 1998).  Once 
phosphorylated by CLK1, the SR protein is capable of movement within the nucleoplasm and 
can bind to nearby large nuclear ribonucleoproteins involved in splicing (Duncan et al., 1997).  
Here, the SR proteins bind to small “exonic splicing enhancers / silencers” (Voet et al., 2008). 
These domains are approximately 5-10 nucleotides long, are located in the exons, and their 
binding can shift the 5‟ splice site (Zahler et al., 1992; Voet et al., 2008).  Past research has 
shown that the selection of these splice sites is done in a SR protein concentration-dependent 
manner (Zahler et al., 1993).  Tissue-specific expression of SR proteins suggests that each SR 
protein is designed for regulating concentrations of proteins necessary for tissue upkeep (Voet et 
al., 2008). 
SR Protein Structure 
 Originally all SR proteins were identified as containing a conserved phosphorylated 
epitope region recognized by monoclonal antibody mAb104, but now SR protein structure is far 
better understood (Roth et al., 1990).  SR proteins have 2 domains, one or two highly conserved 
RNA-recognition motifs (RRM, Figure 6) and a SR domain (Voet et al., 2008).  The RRM(s) 
bind(s) to RNA within the spliceosome, and the SR domain mediates the protein-protein 
interactions (Voet et al., 2008).  Within the SR domain, there is also a serine residue which can 
be phosphorylated, activating the SR protein.  SR proteins are highly conserved in all cells, and 
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Figure 6. RNA Recognition Motifs of Protein 
SRp20. The domain shown is the RNA-binding 
region of the SRp20 protein (the SR domain is not 
shown). (Hargous et al., 2006) 
in a study comparing six cell types across different species, all contained SR proteins of 
approximately 20, 30, 40, 55, and 75 kDa in size (Zahler et al., 1992). 
 
 
 
SRp20 
SR protein 20 (also known as Splicing Factor arginine-serine rich 3, SFRS3) is of interest 
to this MQP study as it is specifically phosphorylated by CLK1 (Roh et al., 2010).  This 
relationship may be important to the regulation of mRNAs responsible for the differentiation of 
epithelial stem cells (Roh et al., 2010).   
SRp20 has only one RRM and is 20 kDa in size (Zahler et al., 1992).  Although all SR 
proteins are highly conserved in the animal kingdom, SRp20 is an especially highly conserved 
SR protein (Zahler et al., 1992; Zahler et al., 1993).   For example, past studies have shown 
SRp20‟s amino acid structure to be completely identical to that of mouse SRp20 (Ayane et al., 
1991).  More recent investigations have shown that SRp20 self-regulates its own pre-mRNA 
splicing, and that SR protein ASF/SF2 inhibits this process, thus inhibiting the production of 
SRp20 (Jumaa & Nielsen, 1997).  This is significant because ASF/SF2 has been shown to 
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interact with CLK1 and is over-expressed in some tumor cells (Menegay et al., 2000; Karni et 
al., 2007). 
Potential Role of CLK1 and SR Proteins in Cancer Cell Proliferation 
 The SFRS1 gene which codes for ASF/SF2 has been determined to be a proto-oncogene 
(Karni et al., 2007).  Mutated ASF/SF2 has the potential to alternatively splice pre-mRNA into 
non-functional or oncogenic forms, which is critical as this SR protein controls the splicing of 
various tumor suppressor genes, kinases, and kinase receptors (Karni et al., 2007).  CLK1 could 
have a possible role in some cancers due to this relationship between CLK1, SRp20, and 
ASF/SF2.  Additionally CLK1 could also be related to some cancers due to its interactions with 
other SR proteins.  Many protein kinases other than CLK1 have been targeted for cancer therapy 
research in the past due to their interactions in important signal transduction cascades, and 
several inhibitors for these kinases have been approved by the FDA for cancer treatment 
(Levitzki, 2003). 
Role of CLK1 and SR Proteins in Stem Cell Differentiation 
Past investigations have suggested that cdc-like kinases are crucial for cellular 
development, as experiments involving mutated CLK in Drosophila resulted in severe 
developmental and differentiation defects (Yun et al., 1994; Yun et al., 2000).  Another study 
showed that CLK1 expression caused PC12 cells to undergo neuronal differentiation (Myers et 
al., 1994; Menegay et al., 2000).  These studies all indicate that CLK1 activity plays an 
important role in cellular differentiation, although the role may differ depending on the tissue. 
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CLK1 and Telogen Stem Cells 
In previous experiments in Dr. Lyle‟s lab, the CLK1 gene was found to be up-regulated 
in the stem cells of human hair follicles (Roh et al., 2010).  The Lyle lab hypothesized that CLK1 
had an integral role in the process of stem cell differentiation, maintaining an undifferentiated 
state of the telogen stem cells.  In order to determine the effects of CLK1 on the differentiation 
of telogen stem cells, preliminary research was performed using constitutively active and 
dominant negative strains of Tel-E6E7 for CLK1.  The study showed that constitutively active 
CLK1 inhibited the differentiation of telogen stem cells into hair follicle cells when induced by 
co-culture with dermal papillae (DP) cells (Roh et al., 2010).  The dominant negative CLK1 
strain of telogen stem cells showed uninhibited differentiation of telogen stem cells into hair 
follicle cells in the presence of differentiation signals (Roh et al., 2010).  Thus, the preliminary 
data indicates that CLK1 may act to maintain the undifferentiated state of telogen stem cells.  In 
order to validate the dominant negative CLK1 results and to eliminate any potentially off-target 
effects of the dominant negative kinase, E6E7 strains that do not contain any functional CLK1 
need to be developed and studied.  Additionally, the effects of CLK1 on other telogen stem cell 
differentiation pathways need to be investigated.     
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PROJECT PURPOSE 
 
As mentioned previously, earlier studies in the Lyle lab using a dominant negative CLK1 
Tel-E6E7 strain need validation by studying clones without endogenous CLK1 in order to 
eliminate the potential for off-target effects during hair follicle differentiation.  Additionally, the 
effects of CLK1 on other Tel-E6E7 differentiation pathways need to be investigated.  To do this, 
several CLK1 knockdown clones will be created to perform differentiation experiments.  Our 
hypothesis is that these differentiation experiments will yield results indicating that CLK1 
maintains telogen stem cell lineage, and inhibits differentiation into sebocyte and epidermal 
cells.  
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METHODOLOGY 
 
Cell Culture 
Culture Media 
 The following table shows each of the media used for culturing and their components.   
Table 1: Summary of All Culture Media and Their Uses 
Media Components Use: 
Keratinocyte Medium 
(KCM) 
 Base medium: DMEM (Dulbecco's 
Modified Eagle Medium) and Hams F12 
(3:1, Gibco) 
 10% FBS (Fetal Bovine Serum) 
 24 mg/L adenine 
 0.1 nM cholera toxin 
 0.4 μg/mL hydrocortisone 
 5 μg/mL T / 2nM T3 
 6.5 μg/mL insulin 
 1% Pen/Strep 
 0.5 mg/L fungizone/amphotericin B 
 pH 7.2 
Creation KCM+EGF medium, 
culture of Tel-E6E7 cells prior to 
epidermal differentiation 
KCM+EGF Medium  Base medium: KCM 
  10nM EGF (epidermal growth factor) 
Culture of all Tel-E6E7 cells 
(including controls and clones) 
J2 Medium  Base medium: High-glucose DMEM 
(Gibco) 
 10% FBS 
 1% Pen/Strep 
Culture of 3T3-J2 cells 
J2-Conditioned Medium  Base medium: J2 
 Co-cultured with 3T3-J2 cells for 2-4 
days, then collected and filter sterilized 
Culture of all Tel-E6E7 
(including controls and clones) 
Sebocyte Medium  Base medium: DMEM and Hams F12 
(1:1, Gibco) 
 6% FBS 
 2% human serum 
 1% Pen/Strep 
 10nM EGF 
Culture of Tel-E6E7 cells prior to 
induction of sebocyte 
differentiation 
Sebocyte Differentiation 
Medium 
 Base medium: Sebocyte Medium 
 10-4 M arachidonic acid 
Induction of sebocyte 
differentiation in Tel-E6E7 cells 
Keratinocyte Growth 
Medium (KGM) 
 PCT Epidermal Keratinocyte Medium, 
calcium-free (CellnTEC, #Cnt-07CF) 
Culture of Tel-E6E7 cells prior to 
induction of epidermal 
differentiation 
Epidermal 
Differentiation Medium 
 Base medium: KGM 
 1.5 mM calcium chloride 
Induction of epidermal 
differentiation in Tel-E6E7 cells 
Freezing Medium  80% FBS 
 20% DMSO (dimethyl sulfuroxide) 
Freezing of cells not in culture 
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Telogen E6/E7 Cell Line Creation and Culture 
The Tel-E6E7 cell line used in this project was provided by the Cancer Biology 
Department of UMass Medical School.  This line was created as previously described in Roh et 
al. 2008.  Skin from human adult scalps was digested to collect the hair follicles and isolate the 
telogen skin stem cells from the bulge region.  The follicles were dissected, and the stem cells 
were isolated, plated, and further cultured in keratinocyte medium (KCM) supplemented with 
epidermal growth factor (EGF) (Roh et al., 2004; Roh et al., 2008).  The primary cell line was 
immortalized by transduction with a retroviral vector (LXSN-16E6E7), selected, and cultured to 
thirty passages in KCM.  The Tel-E6E7 cells remained stable for twelve months of the 
continuous passages and did not form independent colonies in soft agar assays, suggesting that 
the immortalization did not yield cancerous cell properties. 
This line was cultured in medium containing 50% KCM-EGF and 50% J2-conditioned 
medium or 100% KCM-EGF with a feeder layer of 3T3-J2 cells on 10cm plates. 
3T3-J2 Cell Line 
 A 3T3-J2 cell line was used as a feeder cell layer and in co-culture for the making of J2-
conditioned medium.  These cells were provided by the Cancer Biology Department at UMass 
Medical School.  Prior to use as a feeder layer, the cells were treated with a mitomycin C mixture 
(15 µg/mL mitomycin C in DMEM without serum) for two hours to inhibit cell proliferation.  
The cells were then washed, treated with trypsin, counted, and frozen at -80°C until needed.   
Trypsin Stock 
10x stock trypsin was diluted 1:5 with Hanks Balance Salt Solution to give the working 
solution of 2x trypsin.  Stock versene was mixed 1:1 with 2x trypsin to yield a working solution 
of 1x trypsin with versene for use with the 3T3-J2 cells. 
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Culture Passaging 
All cell lines were passaged by the same method.  Cells were washed with 1x PBS 
(phosphate buffer sulfate) and 2x trypsin was used to dislodge the adhered cells from the bottom 
of the plate.  Serum-containing medium was added once cells had lifted, and the cells were then 
transferred to a conical tube.  The suspension was spun at 200G for 5 minutes, then re-plated at 
the desired dilution on a new plate.  
Freezing Cells 
To preserve cells when not in culture, cells were frozen at -80°C.  Plated cells were 
washed with 1x PBS, treated with trypsin, and neutralized with medium as for cell passage.  
Following centrifugation, the cells were resuspended in medium.  Freezing medium was added to 
the cell suspension and the entire mixture was transferred to a cryotube and placed in a cooler in 
the -80°C freezer.  
Thawing Cells 
When it was necessary to thaw frozen cells, the cryotubes were placed in a 50mL conical 
of 70% ethanol and then in a 37°C water bath for several seconds until thawed.  The suspension 
was washed with 5 mL PBS, spun at 200G for 5 minutes.  The cells were resuspended in 1 mL 
medium and plated. 
 
shRNA Knockdown of CLK1 
In order to create a cell line that will express minimal amounts of CLK1 protein, shRNA 
techniques were used to create a knock down.  RNA interference (RNAi) is a method of 
regulating gene expression which results in the down-regulation of gene expression due to the 
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binding of short RNA sequences to complementary mRNA molecules (Voet et al., 2008).  Small 
hairpin RNAs (shRNAs) contain complementary regions separated by a small „loop‟ that causes 
the transcript to fold back on itself forming a „short hairpin‟ (McIntyre & Fanning, 2006).  
Although, this formation is very similar to those formed by naturally occurring microRNAs, 
shRNAs can be specifically designed to inactivate expression of target genes (McIntyre & 
Fanning, 2006).  
The immortalized Tel-E6E7 cell line was transfected with three different shRNA clones 
targeting CLK1, created by and obtained from UMass Medical School shRNA Core.  Polybrene 
(4 mg/mL) was mixed with dilutions of the viral vectors (1:2, 1:10, and 1:20) then applied to 
Tel-E6E7 cells on 6-well plates.  Transfected cells were selected using Puromycin until a non-
transfected control showed 100% death.  Following selection, cells where fed twice weekly as 
described above.  In order to confirm protein knockdown, cellular lysates were collected, 
denatured, and analyzed by Western blots using an anti-CLK1 antibody (Abgen, AP7529). 
 
Sebocyte Differentiation Assay 
 Tel-E6E7 cells were cultured on 6 cm plates on cover slips in 50% KCM+EGF and 50% 
J2-conditioned media until approximately 70% confluent.  The medium was then changed to 
sebocyte medium.  After 24 hours, differentiation was induced by adding sebocyte differentiation 
medium containing 10
-4
 M arachidonic acid to half the wells.  Three days later, cover slips were 
removed and fixed.  Half of the slips were washed twice with propylene glycol twice for five 
minutes each, stained with 0.7% Oil Red O in propylene glycol for seven minutes, and then 
washed once with 85% propylene glycol in distilled water.  These were then viewed with a light 
microscope.  The remaining slips were subjected to immunofluorescence assays for Keratin7 
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(Dako, Clone OV-TL, #M7018), a differentiation marker.  Cell pellets were also lysed and 
analyzed by Western Blots for Keratin 7.  
 
Epidermal Differentiation Assay 
Tel-E6E7 cells were cultured on 6-well plates on cover slips in 50% KCM+EGF and 50% 
J2-conditioned medium until approximately 50% confluent.  The medium was then changed to 
KCM with no EGF supplement.  Twenty-four hours later, the medium was changed to KGM.  
After 24-hour incubation, differentiation was induced in half the wells with epidermal 
differentiation medium containing 1.5 mM calcium chloride.  Three days later, cover slips were 
removed, fixed, and subjected to immunofluorescence assays for Keratin 1 (Santa Cruz Biotech, 
N-20 sc-17091), an epidermal cell marker.  
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RESULTS 
 
The goal of this study was to create Tel-E6E7 knockdown clones lacking CLK1 and 
determine their ability to differentiate along sebocyte and epidermal pathways.  
 
CLK1 Knockdown 
To knockdown CLK1 mRNA, it was first necessary to transfect Tel-E6E7 cells with viral 
vectors encoding shRNAs targeted against the coding region of the CLK1 gene.  The three 
resulting clones each showed a considerable knockdown of CLK1 protein on a Western blot 
(Figure 7, Panel A).  A quantification of the Western blot was done by normalizing the band 
intensity for each clone to that of the actin load marker and the non-transfected control (Figure 
7, Panels B and C).  This analysis showed that clones E3 and H3 provided the best knockdowns, 
with a 14-fold and 10-fold reduction of CLK1, respectively.  Clone D7 showed only a 2.5-fold 
knockdown.  The variation of CLK1 knockdown among the clones is likely due to the different 
affinities for shRNAs binding their mRNA targets, which could result from some binding sites 
existing in mRNA secondary structures less accessible to the shRNAs, or in the knockdown of a 
protein by numerous mechanisms.  
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Figure 7. CLK1 Knockdown. (A) Following transfection of Tel-E6E7 cells with shRNAs and selection, cell 
lysates were collected and analyzed by Western blots for CLK1. (B) Western blot quantification data was 
normalized to the non-transfected (NT) control cell line. This blot shows that all three shRNA experimental clones 
(D7, E3, H3) yielded a knockdown of CLK1 protein; clones E3 and H3 showed the best knockdowns of 14- and 
10-fold, respectively. (C) Table provides information regarding the viral vectors used to make each clone. The 
normalized knockdown reductions of CLK1 are also shown.   
(NT – non-transfected control; NS – non-silencing control; D7, E3, H3 – three different transfected clones)   
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Sebocyte Differentiation Assay 
 Tel-E6E7 cells were cultured in sebocyte medium, and then half were induced to 
differentiate with arachidonic acid.  The resulting cells were analyzed by keratin 7 (K7) 
immunofluorescence assays, Oil Red O staining, and a K7 Western blot (Figure 8).  
In the immunofluorescence assays, the cells were stained for keratin 7 (green), which is 
known to be up-regulated in sebocyte precursor differentiated cells and down-regulated in fully-
differentiated cells (Figure 8, Panel A).  The data show that keratin 7 (K7) is highly 
concentrated in the nuclear region of the non-induced precursor cells (Figure 8, Panel B, non-
induced).  In contrast, in induced cells residual K7 disperses throughout the differentiated cell 
(Figure 8, Panel B, induced).  As shown in the assay photographs of the induced cells, K7 
intensity is reduced and more widespread independent of the knockdown status, suggesting that 
CLK1 is not required for sebocyte differentiation.  
These observations are supported by the Oil Red O stains of the same cells (Figure 8, 
Panel B, right columns).  Round, red droplets indicating the presence fatty lipids of sebaceous 
glands are seen in all induced control and knock down cell lines, but not in non-induced cells.   
The K7 Western blot of cellular lysates from the assayed cells also shows no difference in the 
differentiation pattern between the knockdown clones and the controls (Figure 8, Panels C and 
D).  These results suggest that the absence of CLK1 is not important for sebocyte differentiation. 
  
 
 
 
 No K7 
expressed 
Cellular K7 
expression 
increases 
K7 production 
decreased  
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B. 
D. 
C. 
Figure 8. Sebocyte Differentiation Assay. (A) Panel shows the distribution of keratin 7 during sebocyte differentiation.  (B) 
Immunofluorscence staining for keratin 7 (FITC, green) and cell nuclei (Dapi, blue). When cells are introduced to sebocyte media 
(left-most non-induced panels), they enter a precursor differentiation state in which they express higher levels keratin 7 (K7) 
concentrated near the nucleus. Following induction with arachidonic acid (induced), K7 production is decreased and residual protein 
is dispersed within the cell. The two right columns show Oil Red O staining for fatty lipids, a marker of differentiated sebocytes.  
Larger red droplets as seen in the right-most, induced panels. These assays show equal sebocyte differentiation in both the controls 
and the CLK1 knockdown clone. (C and D) Western blots of cellular lysates shows no difference in K7 expression levels between 
the controls and the knockdown clones. Panel C compares the best knockdown clones to the two controls, while Panel D shows 
another blot comparing all the knockdown clones.  
(NT – non-transfected control; NS – non-silencing control; D7, E3, H3 – three different transfected clones; + induced with 
arachidonic acid; - not induced) 
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Epidermal Differentiation Assay 
 
 Tel-E6E7 cells were cultured in KGM medium, and then half were induced to 
differentiate with 1.5 mM calcium chloride.  The resulting cells were subjected to keratin-1 (K1) 
immunofluorescence assays (Figure 9).  In the immunofluorescence assays, the cells were 
stained for keratin-1 (green), an epidermal cell marker.  The only cells to show the presence of 
K1 (differentiation) were the controls expressing normal levels of CLK1 (Figure 9, upper right 
two panels).  Consistently among the three experimental CLK1 knockdown clones, no K1 was 
observed (Figure 9).  
These results suggest that knockdown of CLK1 significantly reduces epidermal 
differentiation in telogen stem cells; therefore, CLK1 must be necessary for the cells to 
differentiate along this pathway.   
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Figure 9. Epidermal Differentiation Assay. Immunofluorscence staining for 
keratin 1 (FITC, green) and cell nuclei (Dapi, blue). This assay clearly shows 
that the knockdown clones lacking CLK1 (D7, E3, H3) do not express keratin 
1, the marker of epidermal differentiation. This indicates that these 
knockdown cells were unable to differentiate by the epidermal pathway.  
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DISCUSSION 
 
After the successful creation of the Tel-E6E7 CLK1 knockdown clones by shRNA 
transfections, these clones were used in differentiation assays to test their abilities to enter the 
epidermal and sebocyte pathways.  CLK1 did not appear to play a role in sebocyte 
differentiation, but did appear to be necessary in epidermal differentiation.  These results differed 
from the previous Lyle lab experiments which showed that CLK1 maintained telogen stem cells 
and inhibited differentiation into hair follicle cells (Roh et al., 2010).  Thus, we concluded that 
CLK1 plays a different role in each differentiation pathway of Tel-E6E7. 
 Future experiments using the CLK1 knockdown clones should include hair follicle cell 
differentiation in order to validate the CLK1 dominant-negative data obtained by the previous 
study.  This experiment, along with the experiments using the sebocyte and epidermal pathways, 
should be run in triplicate to ensure the reproducibility of the data.  With the data from these 
experiments, Dr. Stephen Lyle will hopefully able to publish his paper and proceed to study the 
effects of CLK1 on other applications. 
 Further investigations of CLK1 could include a potential relationship between CLK1 and 
skin cancers.  Many protein kinases other than CLK1 have been targeted for cancer therapy 
research in the past due to their interactions in important signal transduction cascades, and 
several inhibitors for these kinases have been approved by the FDA for cancer treatment 
(Levitzki, 2003).  CLK1 especially could be a potential therapeutic target due to its involvement 
in the selection of pre-mRNA splice sites by its phosphorylation and subsequent activation of SR 
proteins (Duncan et al., 1997).  Some SR proteins, such as ASF/SF2, have been discovered to 
have oncogenic properties when mutated or rendered non-functional (Karni et al., 2007).  
Furthermore, CLK1 and the SR protein of this study, SRp20, have both been previously shown 
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to interact with ASF/SF2 which is over-expressed in some tumor cells (Jumaa & Nielsen, 1997; 
Menegay et al., 2000; Karni et al., 2007).  Thus, the relationship between CLK1 and skin cancers 
should be considered for investigation. 
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